No new pandemic has emerged in 2026, as global surveillance by the WHO and CDC shows no novel pathogen triggering sustained human-to-human transmission or crossing official epidemic thresholds. Existing respiratory viruses, including influenza strains and SARS-CoV-2 variants, remain at endemic levels with typical seasonal patterns rather than exponential growth. Strong public health infrastructure, rapid genomic sequencing, and historical rarity of pandemics underpin the 94.5% market-implied odds for no event. A realistic challenge could arise from an undetected zoonotic spillover producing a highly transmissible strain that evades current immunity, though no such signals appear in current monitoring data.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
6% probabilidad
$1,028,462 Vol.
$1,028,462 Vol.
30 dic 2026
Sí
6% probabilidad
$1,028,462 Vol.
$1,028,462 Vol.
30 dic 2026
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.No new pandemic has emerged in 2026, as global surveillance by the WHO and CDC shows no novel pathogen triggering sustained human-to-human transmission or crossing official epidemic thresholds. Existing respiratory viruses, including influenza strains and SARS-CoV-2 variants, remain at endemic levels with typical seasonal patterns rather than exponential growth. Strong public health infrastructure, rapid genomic sequencing, and historical rarity of pandemics underpin the 94.5% market-implied odds for no event. A realistic challenge could arise from an undetected zoonotic spillover producing a highly transmissible strain that evades current immunity, though no such signals appear in current monitoring data.
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.
The resolution source will be official announcements from the World Health Organization.
Mercado abierto: Dec 1, 2025, 4:37 PM ET
Volumen
$1,028,462Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 4:37 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.No new pandemic has emerged in 2026, as global surveillance by the WHO and CDC shows no novel pathogen triggering sustained human-to-human transmission or crossing official epidemic thresholds. Existing respiratory viruses, including influenza strains and SARS-CoV-2 variants, remain at endemic levels with typical seasonal patterns rather than exponential growth. Strong public health infrastructure, rapid genomic sequencing, and historical rarity of pandemics underpin the 94.5% market-implied odds for no event. A realistic challenge could arise from an undetected zoonotic spillover producing a highly transmissible strain that evades current immunity, though no such signals appear in current monitoring data.
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.
The resolution source will be official announcements from the World Health Organization.
Volumen
$1,028,462Fecha de finalización
31 dic 2026Mercado abierto
Dec 1, 2025, 4:37 PM ETResolver
0x65070BE91...No new pandemic has emerged in 2026, as global surveillance by the WHO and CDC shows no novel pathogen triggering sustained human-to-human transmission or crossing official epidemic thresholds. Existing respiratory viruses, including influenza strains and SARS-CoV-2 variants, remain at endemic levels with typical seasonal patterns rather than exponential growth. Strong public health infrastructure, rapid genomic sequencing, and historical rarity of pandemics underpin the 94.5% market-implied odds for no event. A realistic challenge could arise from an undetected zoonotic spillover producing a highly transmissible strain that evades current immunity, though no such signals appear in current monitoring data.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes